MORTIMER J. LACHER, M.D.
With the constant use of new chemotherapeutic agents for treatment of cancer, it is inevitable that these agents will eventually be used during pregnancy. The urgent need to define the effect of these agents on the fetus has been amply illustrated by the experience with thalidomide (1, 2).
The following case report illustrates the use of vinblastine sulfate (Velban_) in a pregnant patient with Hodgkin's disease.
A 22-year-old white female first noted a lump in the left neck in October, 1961. In March, 1962, a left cervical node biopsy was diagnosed as Hodgkin's granuloma. A chest X ray
LACHER MJ. Use of Vinblastine Sulfate to Treat Hodgkin's Disease During Pregnancy. Ann Intern Med. ;61:113–115. doi: 10.7326/0003-4819-61-1-113
Download citation file:
© 2019
Published: Ann Intern Med. 1964;61(1):113-115.
DOI: 10.7326/0003-4819-61-1-113
Hematology/Oncology, Leukemia/Lymphoma.